Progress seen in 'miracle' line of attack against genetic disorders

While we advise a strict moratorium on using the word "miracle" to describe brand new approaches to treating disease, researchers have certainly produced some interesting results from studies of ways to address codon signal errors that lead to the production of faulty proteins at play in genetic disorders such as cystic fibrosis and muscular dystrophy. The Telegraph reports today that scientists have figured out a potential way to rewrite the genetic code that leads to the diseases. "The ability to manipulate the production of a protein from a particular gene is the new miracle of modern medicine," the University of Rochester's Robert Bambara tells the British newspaper. Report

Suggested Articles

Novartis unveiled more data showing how its asthma combo QMF149 fared against the standard of care: a combination of the same types of drugs.

Johns Hopkins researchers developed a biodegradable polymer to transport large therapies into cells—including genes and even CRISPR.

UCB’s bispecific antibody recently beat Johnson & Johnson’s Stelara at clearing psoriasis symptoms, and now it has bested AbbVie’s Humira, too.